Nanobiotix Reports Positive Phase I/II Preliminary Data on Feasibility and Safety of NBTXR3 in Liver Cancers Trial
Dec 15, 2016 08:00 HKT |  |
|
Jacobson Pharma Announces Acquisition of 100% Interest in Ho Chai Kung Brand
Dec 13, 2016 09:17 HKT |  |
|
NovogeneAIT Singapore and the Genome Institute of Singapore Forge Public-Private Partnership to Establish Whole Genome Sequencing Centre in Singapore
Dec 08, 2016 09:00 HKT |  |
|
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business
Dec 01, 2016 11:40 HKT |  |
|
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3
Nov 29, 2016 08:00 HKT | |
|
Jacobson Pharma Announces 2016 Interim Results
Nov 23, 2016 21:27 HKT | |
|
Scientists Successfully Create Blood from Skin Cells
Nov 21, 2016 18:00 HKT |  |
|
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage as In Situ Vaccine for Cancer at the Society for Immunotherapy of Cancer Annual Meeting
Nov 14, 2016 15:20 HKT | |
|
The Highs and Lows of Regenerative Medicine
Nov 09, 2016 07:30 HKT |  |
|
Nanobiotix' Partner PharmaEngine Has Launched a New NBTXR3 Clinical Trial in Head and Neck Cancers in Asia
Nov 07, 2016 17:00 HKT | |
|
Shining Light on Disease
Nov 05, 2016 07:20 HKT | |
|
A Chain of Life for a Rare Neurodegenerative Disease
Nov 03, 2016 20:00 HKT | |
|
Imaging the Inside of Cells Using Polymeric Nanoparticles
Nov 01, 2016 07:00 HKT | |
|
Jacobson Pharma Completes Acquisition of Reputable Generic Drug Manufacturer in Hong Kong
Oct 31, 2016 22:00 HKT | |
|
Shanghai Pharmaceuticals Released 2016 Q3 Results
Oct 27, 2016 22:20 HKT |  |
|
Nanobiotix's Partner, PharmaEngine, Has Launched a New NBTXR3 Clinical Trial in Head and Neck Cancers in Asia
Oct 21, 2016 05:00 HKT | |
|
Nanobiotix Strengthens U.S. Leadership with Appointments of Head of U.S. Clinical Development and Director of Investor Relations
Oct 04, 2016 08:00 HKT | |
|
Bpifrance Grants Nanobiotix a 2M EUR Interest-free Loan to Support Final Development Stage of Lead Product, NBTXR3
Sep 20, 2016 07:30 HKT | |
|
Nanobiotix Announces Submission for First Market Approval of Lead Product NBTXR3 in Europe
Sep 14, 2016 08:00 HKT | |
|
Singapore Scientists Develop DNA-altering Technology to Tackle Diseases
Sep 13, 2016 17:30 HKT | |
|